Quoin Pharmaceuticals Ltd. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Quoin Pharmaceuticals Ltd. treasury stock, shares, acquired for the quarter ending 2023-12-31 was -45.00 shares.
- Quoin Pharmaceuticals Ltd. treasury stock, shares, acquired for the quarter ending 2023-09-30 was -2.64M shares.
- Quoin Pharmaceuticals Ltd. treasury stock, shares, acquired for the quarter ending 2023-06-30 was 0.00 shares.
- Quoin Pharmaceuticals Ltd. treasury stock, shares, acquired for the quarter ending 2023-03-31 was 2.64M shares.
- Quoin Pharmaceuticals Ltd. treasury stock, shares, acquired for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- Quoin Pharmaceuticals Ltd. treasury stock, shares, acquired for fiscal 2022 was 45.00 shares, a 100.00% decline from fiscal 2021.
- Quoin Pharmaceuticals Ltd. treasury stock, shares, acquired for fiscal 2021 was 2.64M shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2023-12-31 | -45.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 0.00 shares 10-K · filed 2024-03-14 |
| 2023-09-30 | -2.64M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | |
| 2023-03-31 | 2.64M shares 10-Q · filed 2023-05-09 | |
| 2022-12-31 | 45.00 shares 10-K · filed 2024-03-14 | |
| 2021-12-31 | 2.64M shares 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |